Literature DB >> 4031884

Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells).

R Harder, H Bönisch.   

Abstract

The dependence on Na+, K+, and Cl- of uptake and accumulation of [3H]noradrenaline was studied in plasma membrane vesicles isolated from PC-12 pheochromocytoma cells. Plasma membrane vesicles accumulated [3H]noradrenaline when an inward-directed gradient for Na+ and an outward-directed gradient for K+ were imposed across the vesicle membrane. Under these conditions, initial rates of uptake of [3H]noradrenaline were saturable (Km = 0.14 microM) and inhibited by a series of substrates and inhibitors of "uptake". The IC50 values were positively correlated with those for inhibition of uptake into intact PC-12 cells. Uptake and accumulation of [3H]noradrenaline in plasma membrane vesicles were absolutely dependent on external Na+ and Cl-; they were dependent on an inwardly directed gradient for Na+ but less dependent on an inwardly directed gradient for Cl-. Internal K+ strongly enhanced uptake and accumulation of [3H]noradrenaline. Rb+, but not Li+, had the capacity to replace internal K+. Two explanations are proposed for this effect of internal K+: (a) creation of a K+ diffusion potential (inside negative) provides a driving force for inward transport, and/or (b) K+ increases the turnover rate by formation of a highly mobile potassium-carrier complex. A hypothetical scheme for the transport of noradrenaline is presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031884     DOI: 10.1111/j.1471-4159.1985.tb05536.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.

Authors:  M Syringas; F Janin; B Giros; J Costentin; J J Bonnet
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

Review 3.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

4.  Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.

Authors:  M E Reith; C Xu; L Zhang; L L Coffey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Norepinephrine transporters have channel modes of conduction.

Authors:  A Galli; R D Blakely; L J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  [3H]noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine.

Authors:  D B McKay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  The neuronal noradrenaline transport system of PC-12 cells: kinetic analysis of the interaction between noradrenaline, Na+ and Cl- in transport.

Authors:  U Friedrich; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

8.  Noradrenaline transport and transporter mRNA of rat chromaffin cells are controlled by dexamethasone and nerve growth factor.

Authors:  A R Wakade; T D Wakade; M Poosch; M J Bannon
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

9.  N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-21       Impact factor: 3.000

10.  Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.

Authors:  T Kurz; G Richardt; M Seyfarth; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.